Together with patients’ satisfaction [4, 5], economic evaluation [4–6] and safety issues related to the potential risk of biological contaminations for both nurses and patients [5–7], nurses’ satisfaction constitutes a key perspective for the management of hospitalized patients with diabetes requiring insulin injections. The gene discussed is INS; the disease is diabetes mellitus.